Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799932157> ?p ?o ?g. }
- W2799932157 endingPage "377" @default.
- W2799932157 startingPage "367" @default.
- W2799932157 abstract "This study was designed to study the effect of diet supplementation with an organic acids-based formulation (OABF) on luminal- and mucosa-associated bacteria, concentration of volatile fatty acids (VFA), microbial glycolytic enzyme activity and expression of mucin 2 (MUC2), immunoglobulin A (IgA) and tight junction protein, i.e., zonula occludens-1 (ZO1), zonula occludens-2 (ZO2), claudin-1 (CLDN1), claudin-5 (CLDN5) and occludin (OCLN), genes at the ileal and cecal level. A 2 × 2 factorial design was used having OABF inclusion and avilamycin as main factors. Subsequently, 544 day-old male Cobb broilers were allocated in the following 4 treatments, each with 8 replicates: no additions (CON), 1 g OABF/kg diet (OA), 2.5 mg avilamycin/kg diet (AV) and combination of OA and AV (OAAV). The trial lasted for 42 days. In the ileum, OAAV resulted in lower mucosa-associated total bacteria levels (PO × A = 0.028) compared with AV. In addition, ileal digesta levels of Clostridium perfringens subgroup were decreased by avilamycin (PA = 0.045). Inclusion of OABF stimulated the activity of microbial glycolytic enzymes, whereas avilamycin resulted in lower acetate (PA = 0.021) and higher butyrate (PA = 0.010) molar ratios. Expression of ZO1 and CLDN5 was down-regulated by both OABF (PO = 0.016 and PO = 0.003, respectively) and avilamycin (PA = 0.016 and PA = 0.001, respectively). In addition, CLDN1 was down-regulated in AV compared with CON (PO × A = 0.012). Furthermore, OABF down-regulated MUC2 (PO = 0.027), whereas avilamycin down-regulated nuclear factor kappa B subunit 1 (NFKB1) (PA = 0.024), toll-like receptor 2 family member B (TLR2B) (PA = 0.011) and toll-like receptor 4 (TLR4) (PA = 0.014) expression. In the ceca, OABF inclusion increased digesta levels of Clostridium coccoides (PO = 0.018) and Clostridium leptum (PO = 0.040) subgroups, while it up-regulated MUC2 expression (PO = 0.014). Avilamycin (PA = 0.044) and interaction (PO × A < 0.001) effects for IgA expression were noted, with CON having higher IgA expression compared with AV. In conclusion, new findings regarding OABF inclusion effects on an array of relevant biomarkers for broiler gut ecology have been reported and discussed in parallel with avilamycin effects used as a positive control. This new knowledge is expected to provide a response baseline for follow up trials under various stress and challenge conditions." @default.
- W2799932157 created "2018-05-17" @default.
- W2799932157 creator A5007583857 @default.
- W2799932157 creator A5053769121 @default.
- W2799932157 date "2018-12-01" @default.
- W2799932157 modified "2023-10-18" @default.
- W2799932157 title "Diet supplementation with an organic acids-based formulation affects gut microbiota and expression of gut barrier genes in broilers" @default.
- W2799932157 cites W1578339888 @default.
- W2799932157 cites W1827305558 @default.
- W2799932157 cites W1968582726 @default.
- W2799932157 cites W1968957135 @default.
- W2799932157 cites W1982181592 @default.
- W2799932157 cites W1984439686 @default.
- W2799932157 cites W1984574853 @default.
- W2799932157 cites W1990619325 @default.
- W2799932157 cites W1991262054 @default.
- W2799932157 cites W1998861225 @default.
- W2799932157 cites W2007969933 @default.
- W2799932157 cites W2009818844 @default.
- W2799932157 cites W2014216380 @default.
- W2799932157 cites W2014386182 @default.
- W2799932157 cites W2022872296 @default.
- W2799932157 cites W2024803597 @default.
- W2799932157 cites W2025868512 @default.
- W2799932157 cites W2030880726 @default.
- W2799932157 cites W2040773538 @default.
- W2799932157 cites W2043119557 @default.
- W2799932157 cites W2043202073 @default.
- W2799932157 cites W2049092980 @default.
- W2799932157 cites W2056941041 @default.
- W2799932157 cites W2061016076 @default.
- W2799932157 cites W2063570013 @default.
- W2799932157 cites W2075822096 @default.
- W2799932157 cites W2078603894 @default.
- W2799932157 cites W2082765025 @default.
- W2799932157 cites W2090541228 @default.
- W2799932157 cites W2100002016 @default.
- W2799932157 cites W2102385603 @default.
- W2799932157 cites W2105282343 @default.
- W2799932157 cites W2106126847 @default.
- W2799932157 cites W2106334736 @default.
- W2799932157 cites W2107900089 @default.
- W2799932157 cites W2108244474 @default.
- W2799932157 cites W2112738213 @default.
- W2799932157 cites W2117727476 @default.
- W2799932157 cites W2121433284 @default.
- W2799932157 cites W2122278065 @default.
- W2799932157 cites W2128862717 @default.
- W2799932157 cites W2129295478 @default.
- W2799932157 cites W2133282550 @default.
- W2799932157 cites W2135037543 @default.
- W2799932157 cites W2136500114 @default.
- W2799932157 cites W2137448333 @default.
- W2799932157 cites W2141727392 @default.
- W2799932157 cites W2149142914 @default.
- W2799932157 cites W2151350595 @default.
- W2799932157 cites W2156235721 @default.
- W2799932157 cites W2158815301 @default.
- W2799932157 cites W2165349948 @default.
- W2799932157 cites W2175635646 @default.
- W2799932157 cites W2228687373 @default.
- W2799932157 cites W2302082427 @default.
- W2799932157 cites W2599800969 @default.
- W2799932157 doi "https://doi.org/10.1016/j.aninu.2018.03.007" @default.
- W2799932157 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6284220" @default.
- W2799932157 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30564756" @default.
- W2799932157 hasPublicationYear "2018" @default.
- W2799932157 type Work @default.
- W2799932157 sameAs 2799932157 @default.
- W2799932157 citedByCount "23" @default.
- W2799932157 countsByYear W27999321572019 @default.
- W2799932157 countsByYear W27999321572020 @default.
- W2799932157 countsByYear W27999321572021 @default.
- W2799932157 countsByYear W27999321572022 @default.
- W2799932157 countsByYear W27999321572023 @default.
- W2799932157 crossrefType "journal-article" @default.
- W2799932157 hasAuthorship W2799932157A5007583857 @default.
- W2799932157 hasAuthorship W2799932157A5053769121 @default.
- W2799932157 hasBestOaLocation W27999321571 @default.
- W2799932157 hasConcept C100544194 @default.
- W2799932157 hasConcept C104317684 @default.
- W2799932157 hasConcept C150194340 @default.
- W2799932157 hasConcept C177779419 @default.
- W2799932157 hasConcept C179264091 @default.
- W2799932157 hasConcept C2775962179 @default.
- W2799932157 hasConcept C2776979534 @default.
- W2799932157 hasConcept C2777116383 @default.
- W2799932157 hasConcept C2777226302 @default.
- W2799932157 hasConcept C2779116991 @default.
- W2799932157 hasConcept C2780255968 @default.
- W2799932157 hasConcept C2781092032 @default.
- W2799932157 hasConcept C31903555 @default.
- W2799932157 hasConcept C523546767 @default.
- W2799932157 hasConcept C54355233 @default.
- W2799932157 hasConcept C55493867 @default.
- W2799932157 hasConcept C86803240 @default.
- W2799932157 hasConcept C89423630 @default.
- W2799932157 hasConceptScore W2799932157C100544194 @default.